{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:36:49Z","timestamp":1794026209325,"version":"4.8.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"University of Chinese Academy of Sciences, Wenzhou Institute","award":["WIUCASQD2021046"],"award-info":[{"award-number":["WIUCASQD2021046"]}]},{"DOI":"10.13039\/501100018553","name":"Science and Technology Plan Project of Wenzhou Municipality","doi-asserted-by":"publisher","award":["2023Y0847"],"award-info":[{"award-number":["2023Y0847"]}],"id":[{"id":"10.13039\/501100018553","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LQ24H120002"],"award-info":[{"award-number":["LQ24H120002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-024-02724-w","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T03:46:05Z","timestamp":1722915965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Sustained release of 5-aminosalicylic acid from azoreductase-responsive polymeric prodrugs for prolonged colon-targeted colitis therapy"],"prefix":"10.1186","volume":"22","author":[{"given":"Sicheng","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjie","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujun","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"2724_CR1","doi-asserted-by":"crossref","unstructured":"Ouyang J, Zhang Z, Deng B, Liu J, Wang L, Liu H, Koo S, Chen S, Li Y, Yaremenko AV, et al. Oral drug delivery platforms for biomedical applications. Materials Today; 2023.","DOI":"10.1016\/j.mattod.2023.01.002"},{"issue":"5","key":"2724_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","volume":"22","author":"TH Baryakova","year":"2023","unstructured":"Baryakova TH, Pogostin BH, Langer R, McHugh KJ. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Disc. 2023;22(5):387\u2013409.","journal-title":"Nat Rev Drug Disc"},{"issue":"9","key":"2724_CR3","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1002\/jps.22568","volume":"100","author":"B Wu","year":"2011","unstructured":"Wu B, Kulkarni K, Basu S, Zhang S, Hu M. First-pass metabolism via udp-glucuronosyltransferase: a barrier to oral bioavailability of phenolics. J Pharm Sci. 2011;100(9):3655\u201381.","journal-title":"J Pharm Sci"},{"key":"2724_CR4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jconrel.2016.06.016","volume":"240","author":"AA Date","year":"2016","unstructured":"Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: design, evaluation and state-of-the-art. J Control Release. 2016;240:504\u201326.","journal-title":"J Control Release"},{"key":"2724_CR5","first-page":"2306081","volume":"1","author":"B Deng","year":"2023","unstructured":"Deng B, Liu S, Wang Y, Ali B, Kong N, Xie T, Koo S, Ouyang J, Tao W. Oral nanomedicine: challenges and opportunities. Adv Mater. 2023;1:2306081.","journal-title":"Adv Mater"},{"issue":"8","key":"2724_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nrd.2018.46","volume":"17","author":"J Rautio","year":"2018","unstructured":"Rautio J, Meanwell NA, Di L, Hageman MJ. The expanding role of prodrugs in contemporary drug design and development. Nat Rev Drug Disc. 2018;17(8):559\u201387.","journal-title":"Nat Rev Drug Disc"},{"issue":"1","key":"2724_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.drudis.2013.08.014","volume":"19","author":"S-D Clas","year":"2014","unstructured":"Clas S-D, Sanchez RI, Nofsinger R. Chemistry-enabled drug delivery (prodrugs): recent progress and challenges. Drug Disc Today. 2014;19(1):79\u201387.","journal-title":"Drug Disc Today"},{"issue":"3","key":"2724_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/ecco-jcc\/jjaa172","volume":"15","author":"K Matsuoka","year":"2021","unstructured":"Matsuoka K, Igarashi A, Sato N, Isono Y, Gouda M, Iwasaki K, Shoji A, Hisamatsu T. Trends in corticosteroid prescriptions for ulcerative colitis and factors associated with long-term corticosteroid use: analysis using japanese claims data from 2006 to 2016. J Crohn\u2019s Colitis. 2021;15(3):358\u201366.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"6","key":"2724_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/17474124.2019.1604219","volume":"13","author":"M Salice","year":"2019","unstructured":"Salice M, Rizzello F, Calabrese C, Calandrini L, Gionchetti P. A current overview of corticosteroid use in active ulcerative colitis. Exp Rev Gastroenterol Hepatol. 2019;13(6):557\u201361.","journal-title":"Exp Rev Gastroenterol Hepatol"},{"issue":"1","key":"2724_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000527452","volume":"104","author":"Y Mikami","year":"2023","unstructured":"Mikami Y, Tsunoda J, Suzuki S, Mizushima I, Kiyohara H, Kanai T. Significance of 5-aminosalicylic acid intolerance in the clinical management of ulcerative colitis. Digestion. 2023;104(1):58\u201365.","journal-title":"Digestion"},{"issue":"1","key":"2724_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2021-000853","volume":"9","author":"E Louis","year":"2022","unstructured":"Louis E, Paridaens K, Al Awadhi S, Begun J, Cheon JH, Dignass AU, Magro F, M\u00e1rquez JR, Moschen AR, Narula N, et al. Modelling the benefits of an optimised treatment strategy for 5-asa in mild-to-moderate ulcerative colitis. BMJ Open Gastroenterol. 2022;9(1): 000853.","journal-title":"BMJ Open Gastroenterol"},{"issue":"12","key":"2724_CR12","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/apt.14688","volume":"47","author":"P Sehgal","year":"2018","unstructured":"Sehgal P, Colombel J-F, Aboubakr A, Narula N. Systematic review: safety of mesalazine in ulcerative colitis. Aliment Pharmacol Therap. 2018;47(12):1597\u2013609.","journal-title":"Aliment Pharmacol Therap"},{"issue":"6","key":"2724_CR13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1365-2036.2008.03751.x","volume":"28","author":"G Lichtenstein","year":"2008","unstructured":"Lichtenstein G, Kamm M. 5-aminosalicylate formulations for the treatment of ulcerative colitis-methods of comparing release rates and delivery of 5-aminosalicylate to the colonic mucosa. Aliment Pharmacol Therap. 2008;28(6):663\u201373.","journal-title":"Aliment Pharmacol Therap"},{"issue":"1","key":"2724_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","volume":"16","author":"T Raine","year":"2022","unstructured":"Raine T, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V, Bachmann O, Bettenworth D, Chaparro M, Czuber-Dochan W, et al. Ecco guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohn\u2019s Colitis. 2022;16(1):2\u201317.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"13","key":"2724_CR15","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","volume":"381","author":"BE Sands","year":"2019","unstructured":"Sands BE, Sandborn WJ, Panaccione R, O\u2019Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, et al. Ustekinumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2019;381(13):1201\u201314.","journal-title":"N Engl J Med"},{"key":"2724_CR16","first-page":"1","volume":"6","author":"K Taku","year":"2020","unstructured":"Taku K, Britta S, Chen WS, Ferrante M, Shen B, Bernstein CN, Silvio D, Laurent P-B, Toshifumi H, et al. Ulcerative colitis (primer). Nat Rev. 2020;6:1.","journal-title":"Nat Rev"},{"issue":"10","key":"2724_CR17","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1080\/14656566.2016.1187132","volume":"17","author":"M Chaparro","year":"2016","unstructured":"Chaparro M, Gisbert JP. Maintenance therapy options for ulcerative colitis. Exp Opin Pharmacother. 2016;17(10):1339\u201349.","journal-title":"Exp Opin Pharmacother"},{"issue":"10","key":"2724_CR18","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/1744666X.2017.1343668","volume":"13","author":"J Pan\u00e9s","year":"2017","unstructured":"Pan\u00e9s J, Alfaro I. New treatment strategies for ulcerative colitis. Exp Rev Clin Immunol. 2017;13(10):963\u201373.","journal-title":"Exp Rev Clin Immunol"},{"key":"2724_CR19","doi-asserted-by":"crossref","unstructured":"Hu S, Zhao R, Xu Y, Gu Z, Zhu B, Hu J. Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances. Journal of Materials Chemistry B. 2024.","DOI":"10.1039\/D3TB02302H"},{"issue":"1","key":"2724_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41551-022-00972-5","volume":"7","author":"R Wang","year":"2023","unstructured":"Wang R, Cao S, Bashir MEH, Hesser LA, Su Y, Hong SMC, Thompson A, Culleen E, Sabados M, Dylla NP, et al. Treatment of peanut allergy and colitis in mice via the intestinal release of butyrate from polymeric micelles. Nat Biomed Eng. 2023;7(1):38\u201355.","journal-title":"Nat Biomed Eng"},{"issue":"5","key":"2724_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1177\/08853282221122907","volume":"37","author":"F Fardafshari","year":"2022","unstructured":"Fardafshari F, Taymouri S, Minaiyan M, Tavakoli N. Preparing simvastatin nanoparticles by a combination of ph-sensitive and timed-release approaches for the potential treatment of ulcerative colitis. J Biomater Appl. 2022;37(5):859\u201371.","journal-title":"J Biomater Appl"},{"issue":"1","key":"2724_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12951-022-01299-8","volume":"20","author":"X Yan","year":"2022","unstructured":"Yan X, Yang C, Yang M, Ma Y, Zhang Y, Zhang Y, Liu C, Xu Q, Tu K, Zhang M. All-in-one theranostic nano-platform based on polymer nanoparticles for bret\/fret-initiated bioluminescence imaging and synergistically anti-inflammatory therapy for ulcerative colitis. J Nanobiotechnol. 2022;20(1):99.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"2724_CR23","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3390\/pharmaceutics14061233","volume":"14","author":"C Yang","year":"2022","unstructured":"Yang C, Sung J, Long D, Alghoul Z, Merlin D. Prevention of ulcerative colitis by autologous metabolite transfer from colitogenic microbiota treated with lipid nanoparticles encapsulating an anti-inflammatory drug candidate. Pharmaceutics. 2022;14(6):1233.","journal-title":"Pharmaceutics"},{"issue":"5","key":"2724_CR24","doi-asserted-by":"publisher","first-page":"20200126","DOI":"10.1002\/VIW.20200126","volume":"2","author":"A Geraili","year":"2021","unstructured":"Geraili A, Xing M, Mequanint K. Design and fabrication of drug-delivery systems toward adjustable release profiles for personalized treatment. View. 2021;2(5):20200126.","journal-title":"View"},{"key":"2724_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","volume":"332","author":"M Ghezzi","year":"2021","unstructured":"Ghezzi M, Pescina S, Padula C, Santi P, Del Favero E, Cant\u00f9 L, Nicoli S. Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions. J Control Release. 2021;332:312\u201336.","journal-title":"J Control Release"},{"issue":"31","key":"2724_CR26","doi-asserted-by":"publisher","first-page":"2301518","DOI":"10.1002\/adhm.202301518","volume":"12","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wu Y, Yan Y, Ma Y, Tu L, Shao J, Tang X, Chen L, Liang G, Yin L. Dual-targeted nanoparticle-in-microparticle system for ulcerative colitis therapy. Adv Healthcare Mater. 2023;12(31):2301518.","journal-title":"Adv Healthcare Mater"},{"issue":"4","key":"2724_CR27","doi-asserted-by":"publisher","first-page":"2205422","DOI":"10.1002\/advs.202205422","volume":"10","author":"K Zhang","year":"2023","unstructured":"Zhang K, Zhu L, Zhong Y, Xu L, Lang C, Chen J, Yan F, Li J, Qiu J, Chen Y, et al. Prodrug integrated envelope on probiotics to enhance target therapy for ulcerative colitis. Adv Sci. 2023;10(4):2205422.","journal-title":"Adv Sci"},{"issue":"15","key":"2724_CR28","doi-asserted-by":"publisher","first-page":"14718","DOI":"10.1021\/acsnano.3c02646","volume":"17","author":"P Peng","year":"2023","unstructured":"Peng P, Feng T, Yang X, Nie C, Yu L, Ding R, Zhou Q, Jiang X, Li P. Gastrointestinal microenvironment responsive nanoencapsulation of probiotics and drugs for synergistic therapy of intestinal diseases. ACS Nano. 2023;17(15):14718\u201330.","journal-title":"ACS Nano"},{"key":"2724_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","volume":"124","author":"JT Huckaby","year":"2018","unstructured":"Huckaby JT, Lai SK. Pegylation for enhancing nanoparticle diffusion in mucus. Adv Drug Deliv Rev. 2018;124:125\u201339.","journal-title":"Adv Drug Deliv Rev"},{"key":"2724_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jconrel.2014.10.026","volume":"197","author":"K Maisel","year":"2015","unstructured":"Maisel K, Ensign L, Reddy M, Cone R, Hanes J. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. J Control Rel. 2015;197:48\u201357.","journal-title":"J Control Rel"},{"issue":"1","key":"2724_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-022-01539-x","volume":"20","author":"DA Subramanian","year":"2022","unstructured":"Subramanian DA, Langer R, Traverso G. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems. J Nanobiotechnol. 2022;20(1):1\u201323.","journal-title":"J Nanobiotechnol"},{"issue":"4","key":"2724_CR32","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","volume":"116","author":"N Kamaly","year":"2016","unstructured":"Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev. 2016;116(4):2602\u201363.","journal-title":"Chem Rev"},{"issue":"1","key":"2724_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40580-016-0061-2","volume":"3","author":"S Bohrey","year":"2016","unstructured":"Bohrey S, Chourasiya V, Pandey A. Polymeric nanoparticles containing diazepam: preparation, optimization, characterization, in-vitro drug release and release kinetic study. Nano Convergence. 2016;3(1):1\u20137.","journal-title":"Nano Convergence"},{"key":"2724_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40005-017-0320-1","volume":"47","author":"G-H Son","year":"2017","unstructured":"Son G-H, Lee B-J, Cho C-W. Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles. J Pharmac Invest. 2017;47:287\u201396.","journal-title":"J Pharmac Invest"},{"issue":"1","key":"2724_CR35","doi-asserted-by":"publisher","first-page":"21335","DOI":"10.1038\/srep21335","volume":"6","author":"B Tian","year":"2016","unstructured":"Tian B, Liu S, Lu W, Jin L, Li Q, Shi Y, Li C, Wang Z, Du Y. Construction of ph-responsive and up-conversion luminescent nayf4: Yb3+\/er3+@ sio2@ pmaa nanocomposite for colon targeted drug delivery. Sci Rep. 2016;6(1):21335.","journal-title":"Sci Rep"},{"issue":"3","key":"2724_CR36","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3892\/mmr.2017.6153","volume":"15","author":"H Tang","year":"2017","unstructured":"Tang H, Xiang D, Wang F, Mao J, Tan X, Wang Y. 5-asa-loaded sio2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice. Mol Med Rep. 2017;15(3):1117\u201322.","journal-title":"Mol Med Rep"},{"key":"2724_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103578","volume":"74","author":"N Wang","year":"2022","unstructured":"Wang N, Shao L, Lu W, Fang W, Zhang Q, Sun L, Gao S, Zhu Q, Chen S, Hu R. 5-aminosalicylic acid ph sensitive core-shell nanoparticles targeting ulcerative colitis. J Drug Del Sci Technol. 2022;74: 103578.","journal-title":"J Drug Del Sci Technol"},{"issue":"5","key":"2724_CR38","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1021\/acsmacrolett.3c00163","volume":"12","author":"S Tang","year":"2023","unstructured":"Tang S, Yang R, Gao Y, Zhu L, Zheng S, Zan X. Hydrazone-based amphiphilic brush polymer for fast endocytosis and ros-active drug release. ACS Macro Lett. 2023;12(5):639\u201345.","journal-title":"ACS Macro Lett"},{"issue":"1","key":"2724_CR39","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1038\/s41467-019-11885-4","volume":"10","author":"G Naren","year":"2019","unstructured":"Naren G, Hsu C-W, Li S, Morimoto M, Tang S, Hernando J, Guirado G, Irie M, Raymo FM, Sund\u00e9n H, et al. An all-photonic full color rgb system based on molecular photoswitches. Nat Commun. 2019;10(1):3996.","journal-title":"Nat Commun"},{"issue":"13","key":"2724_CR40","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1021\/jacs.8b00887","volume":"140","author":"S Tang","year":"2018","unstructured":"Tang S, Zhang Y, Dhakal P, Ravelo L, Anderson CL, Collins KM, Raymo FM. Photochemical barcodes. J Am Chem Soc. 2018;140(13):4485\u20138.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"2724_CR41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1021\/acssensors.6b00592","volume":"2","author":"S Tang","year":"2017","unstructured":"Tang S, Zhang Y, Thapaliya ER, Brown AS, Wilson JN, Raymo FM. Highlighting cancer cells with halochromic switches. ACS Sens. 2017;2(1):92\u2013101.","journal-title":"ACS Sens"},{"issue":"15","key":"2724_CR42","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1039\/C7NR00839B","volume":"9","author":"A Pietropaolo","year":"2017","unstructured":"Pietropaolo A, Tang S, Raymo FM. Free-energy predictions and absorption spectra calculations for supramolecular nanocarriers and their photoactive cargo. Nanoscale. 2017;9(15):4989\u201394.","journal-title":"Nanoscale"},{"issue":"34","key":"2724_CR43","doi-asserted-by":"publisher","first-page":"8676","DOI":"10.1021\/acs.langmuir.6b01549","volume":"32","author":"S Tang","year":"2016","unstructured":"Tang S, Donaphon B, Levitus M, Raymo FM. Structural implications on the properties of self-assembling supramolecular hosts for fluorescent guests. Langmuir. 2016;32(34):8676\u201387.","journal-title":"Langmuir"},{"issue":"14","key":"2724_CR44","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1021\/ja5125308","volume":"137","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Swaminathan S, Tang S, Garcia-Amor\u00f3s J, Boulina M, Captain B, Baker JD, Raymo FM. Photoactivatable bodipys designed to monitor the dynamics of supramolecular nanocarriers. J Am Chem Soc. 2015;137(14):4709\u201319.","journal-title":"J Am Chem Soc"},{"issue":"33","key":"2724_CR45","doi-asserted-by":"publisher","first-page":"14071","DOI":"10.1039\/C5NR02672E","volume":"7","author":"S Swaminathan","year":"2015","unstructured":"Swaminathan S, Fowley C, Thapaliya ER, McCaughan B, Tang S, Fraix A, Captain B, Sortino S, Callan JF, Raymo FM. Supramolecular nanoreactors for intracellular singlet-oxygen sensitization. Nanoscale. 2015;7(33):14071\u20139.","journal-title":"Nanoscale"},{"issue":"1","key":"2724_CR46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1021\/acsmacrolett.3c00668","volume":"13","author":"S Tang","year":"2023","unstructured":"Tang S, Gao Y, Wang W, Wang Y, Liu P, Shou Z, Yang R, Jin C, Zan X, Wang C, et al. Self-report amphiphilic polymer-based drug delivery system with ros-triggered drug release for osteoarthritis therapy. ACS Macro Lett. 2023;13(1):58\u201364.","journal-title":"ACS Macro Lett"},{"issue":"4","key":"2724_CR47","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/jbm.a.36305","volume":"106","author":"Z Davoudi","year":"2018","unstructured":"Davoudi Z, Peroutka-Bigus N, Bellaire B, Wannemuehler M, Barrett TA, Narasimhan B, Wang Q. Intestinal organoids containing poly (lactic-co-glycolic acid) nanoparticles for the treatment of inflammatory bowel diseases. J Biomed Mater Res, Part A. 2018;106(4):876\u201386.","journal-title":"J Biomed Mater Res, Part A"},{"issue":"6","key":"2724_CR48","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.1021\/acs.jmedchem.1c02166","volume":"65","author":"J Zhao","year":"2022","unstructured":"Zhao J, Zhang B, Mao Q, Ping K, Zhang P, Lin F, Liu D, Feng Y, Sun M, Zhang Y, et al. Discovery of a colon-targeted azo prodrug of tofacitinib through the establishment of colon-specific delivery systems constructed by 5-asa-paba-mac and 5-asa-paba-diamine for the treatment of ulcerative colitis. J Med Chem. 2022;65(6):4926\u201348.","journal-title":"J Med Chem"},{"issue":"18","key":"2724_CR49","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1021\/jm010852p","volume":"44","author":"E Carceller","year":"2001","unstructured":"Carceller E, Salas J, Merlos M, Giral M, Ferrando R, Escamilla I, Ramis J, Garc\u00eda-Rafanell J, Forn J. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity. J Med Chem. 2001;44(18):3001\u201313.","journal-title":"J Med Chem"},{"issue":"6","key":"2724_CR50","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1021\/acs.molpharmaceut.6b00294","volume":"13","author":"W Kim","year":"2016","unstructured":"Kim W, Nam J, Lee S, Jeong S, Jung Y. 5-aminosalicylic acid azo-linked to procainamide acts as an anticolitic mutual prodrug via additive inhibition of nuclear factor kappab. Mol Pharm. 2016;13(6):2126\u201335.","journal-title":"Mol Pharm"},{"issue":"1","key":"2724_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1021\/acs.molpharmaceut.9b00872","volume":"17","author":"S Jeong","year":"2019","unstructured":"Jeong S, Lee H, Kim S, Ju S, Kim W, Cho H, Kim HY, Heo G, Im E, Yoo J-W, et al. 5-aminosalicylic acid azo-coupled with a gpr109a agonist is a colon-targeted anticolitic codrug with a reduced risk of skin toxicity. Mol Pharm. 2019;17(1):167\u201379.","journal-title":"Mol Pharm"},{"key":"2724_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103754","volume":"76","author":"P Dutta","year":"2022","unstructured":"Dutta P, Mukherjee K, Saha A, Das A, Badwaik HR, Giri TK. Colonic delivery of surface charge decorated nanocarrier for ibd therapy. J Drug Del Sci Technol. 2022;76: 103754.","journal-title":"J Drug Del Sci Technol"},{"key":"2724_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.dyepig.2023.111512","volume":"218","author":"L Guo","year":"2023","unstructured":"Guo L, Zhuge Y, Yang L, Qiu H, Liu J, Wang P. A two-photon mitochondria-targeting azo reductase probe for imaging in tumor cells and mice. Dyes Pigm. 2023;218: 111512.","journal-title":"Dyes Pigm"},{"issue":"5","key":"2724_CR54","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1039\/D3MH00018D","volume":"10","author":"J-J Li","year":"2023","unstructured":"Li J-J, Rong R-X, Yang Y, Hu Z-Y, Hu B, Zhao Y-Y, Li H-B, Hu X-Y, Wang K-R, Guo D-S. Triple targeting host-guest drug delivery system based on lactose-modified azocalix [4] arene for tumor ablation. Mater Horizons. 2023;10(5):1689\u201396.","journal-title":"Mater Horizons"},{"issue":"6","key":"2724_CR55","doi-asserted-by":"publisher","first-page":"2104349","DOI":"10.1002\/advs.202104349","volume":"9","author":"X Hou","year":"2022","unstructured":"Hou X, Chang Y-X, Yue Y-X, Wang Z-H, Ding F, Li Z-H, Li H-B, Xu Y, Kong X, Huang F, et al. Supramolecular radiosensitizer based on hypoxia-responsive macrocycle. Adv Sci. 2022;9(6):2104349.","journal-title":"Adv Sci"},{"issue":"3","key":"2724_CR56","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0378-5173(87)90129-3","volume":"35","author":"S Sangekar","year":"1987","unstructured":"Sangekar S, Vadino W, Chaudry I, Parr A, Beihn R, Digenis G. Evaluation of the effect of food and specific gravity of tablets on gastric retention time. Int J Pharm. 1987;35(3):187\u201391.","journal-title":"Int J Pharm"},{"issue":"2","key":"2724_CR57","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0168-3659(98)00154-0","volume":"58","author":"F Kedzierewicz","year":"1999","unstructured":"Kedzierewicz F, Thouvenot P, Lemut J, Etienne A, Hoffman M, Maincent P. Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy. J Control Rel. 1999;58(2):195\u2013205.","journal-title":"J Control Rel"},{"issue":"9","key":"2724_CR58","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.trac.2006.03.010","volume":"25","author":"M Intawongse","year":"2006","unstructured":"Intawongse M, Dean JR. In-vitro testing for assessing oral bioaccessibility of trace metals in soil and food samples. TrAC, Trends Anal Chem. 2006;25(9):876\u201386.","journal-title":"TrAC, Trends Anal Chem"},{"issue":"4","key":"2724_CR59","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ejps.2004.11.005","volume":"24","author":"VH Sunesen","year":"2005","unstructured":"Sunesen VH, Vedelsdal R, Kristensen HG, Christrup L, M\u00fcllertz A. Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug. Eur J Pharm Sci. 2005;24(4):297\u2013303.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"2724_CR60","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1021\/jf9032975","volume":"58","author":"S Roowi","year":"2010","unstructured":"Roowi S, Stalmach A, Mullen W, Lean ME, Edwards CA, Crozier A. Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans. J Agric Food Chem. 2010;58(2):1296\u2013304.","journal-title":"J Agric Food Chem"},{"issue":"3","key":"2724_CR61","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0278-6915(02)00235-1","volume":"41","author":"E Koyama","year":"2003","unstructured":"Koyama E, Kitazawa K, Ohori Y, Izawa O, Kakegawa K, Fujino A, Ui M. In vitro metabolism of the glycosidic sweeteners, stevia mixture and enzymatically modified stevia in human intestinal microflora. Food Chem Toxicol. 2003;41(3):359\u201374.","journal-title":"Food Chem Toxicol"},{"issue":"22","key":"2724_CR62","doi-asserted-by":"publisher","first-page":"10521","DOI":"10.1021\/jf802111x","volume":"56","author":"KH Cha","year":"2008","unstructured":"Cha KH, Koo SY, Lee D-U. Antiproliferative effects of carotenoids extracted from chlorella ellipsoidea and chlorella vulgaris on human colon cancer cells. J Agric Food Chem. 2008;56(22):10521\u20136.","journal-title":"J Agric Food Chem"},{"issue":"16","key":"2724_CR63","first-page":"2008","volume":"12","author":"A Chevalier","year":"2017","unstructured":"Chevalier A, Renard P-Y, Romieu A. Azo-based fluorogenic probes for biosensing and bioimaging: Recent advances and upcoming challenges. Chemistry. 2017;12(16):2008\u201328.","journal-title":"Chemistry"},{"issue":"10","key":"2724_CR64","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1002\/ange.202012764","volume":"133","author":"H Yanai","year":"2021","unstructured":"Yanai H, Hoshikawa S, Moriiwa Y, Shoji A, Yanagida A, Matsumoto T. A fluorinated carbanionic substituent for improving water solubility and lipophilicity of fluorescent dyes. Angew Chem. 2021;133(10):5228\u201332.","journal-title":"Angew Chem"},{"key":"2724_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2019.03.025","volume":"136","author":"K Yasukawa","year":"2019","unstructured":"Yasukawa K, Hirago A, Yamada K, Tun X, Ohkuma K, Utsumi H. In vivo redox imaging of dextran sodium sulfate-induced colitis in mice using overhauser-enhanced magnetic resonance imaging. Free Radical Biol Med. 2019;136:1\u201311.","journal-title":"Free Radical Biol Med"},{"issue":"1","key":"2724_CR66","first-page":"15","volume":"104","author":"B Chassaing","year":"2014","unstructured":"Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (dss)-induced colitis in mice. Curr Prot Immunol. 2014;104(1):15\u201325.","journal-title":"Curr Prot Immunol"},{"issue":"1","key":"2724_CR67","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1443-1661.2009.00916.x","volume":"22","author":"F Hirai","year":"2010","unstructured":"Hirai F, Matsui T, Aoyagi K, Inoue N, Hibi T, Oshitani N, Fujii H, Kobayashi K, Suzuki Y, Tanaka S. Validity of activity indices in ulcerative colitis: comparison of clinical and endoscopic indices. Dig Endosc. 2010;22(1):39\u201344.","journal-title":"Dig Endosc"},{"issue":"3","key":"2724_CR68","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3390\/nu13030773","volume":"13","author":"JP Veenstra","year":"2021","unstructured":"Veenstra JP, Vemu B, Tocmo R, Nauman MC, Johnson JJ. Pharmacokinetic analysis of carnosic acid and carnosol in standardized rosemary extract and the effect on the disease activity index of dss-induced colitis. Nutrients. 2021;13(3):773.","journal-title":"Nutrients"},{"key":"2724_CR69","first-page":"3678","volume":"60","author":"JJ Kim","year":"2012","unstructured":"Kim JJ, Shajib MS, Manocha MM, Khan WI. Investigating intestinal inflammation in dss-induced model of ibd. J Visual Exp. 2012;60:3678.","journal-title":"J Visual Exp"},{"key":"2724_CR70","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.foodres.2017.12.058","volume":"106","author":"Y Kim","year":"2018","unstructured":"Kim Y, Lim HJ, Jang H-J, Lee S, Jung K, Lee SW, Lee S-J, Rho M-C. Portulaca oleracea extracts and their active compounds ameliorate inflammatory bowel diseases in vitro and in vivo by modulating tnf-$$\\alpha$$, il-6 and il-1$$\\beta$$ signalling. Food Res Int. 2018;106:335\u201343.","journal-title":"Food Res Int"},{"key":"2724_CR71","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00005-009-0031-z","volume":"57","author":"A Szkaradkiewicz","year":"2009","unstructured":"Szkaradkiewicz A, Marciniak R, Chudzicka-Struga\u0142a I, Wasilewska A, Drews M, Majewski P, Karpi\u0144ski T, Zwo\u017adziak B. Proinflammatory cytokines and il-10 in inflammatory bowel disease and colorectal cancer patients. Archivum immunologiae et therapiae experimentalis. 2009;57:291\u20134.","journal-title":"Archivum immunologiae et therapiae experimentalis"},{"issue":"1","key":"2724_CR72","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.1038\/s41467-021-27463-6","volume":"12","author":"P Zhao","year":"2021","unstructured":"Zhao P, Xia X, Xu X, Leung KKC, Rai A, Deng Y, Yang B, Lai H, Peng X, Shi P, et al. Nanoparticle-assembled bioadhesive coacervate coating with prolonged gastrointestinal retention for inflammatory bowel disease therapy. Nat Commun. 2021;12(1):7162.","journal-title":"Nat Commun"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02724-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-02724-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02724-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T04:04:31Z","timestamp":1722917071000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-02724-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2724"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-02724-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"20 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments conducted in this study were performed in strict accordance with the guidelines and regulations set forth by the Wenzhou Institute, UCAS. This study was approved by the WIUCAS Animal Ethics Committee, with the approval certificate number WIUCAS23033101.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"468"}}